| Literature DB >> 11791179 |
Yoshiaki Adachi1, Nirmala Chandrasekar, Yoshiaki Kin, Sajani S Lakka, Sanjeeva Mohanam, Niranjan Yanamandra, Pamarthi M Mohan, Gregory N Fuller, Bingliang Fang, Juan Fueyo, Dzung H Dinh, William C Olivero, Takashi Tamiya, Takashi Ohmoto, Anthanassios P Kyritsis, Jasti S Rao.
Abstract
Our previous studies showed that the urokinase-type plasminogen activator receptor (uPAR) and the p16 tumor suppressor gene play a significant role in glioma invasion. We expected that downregulation of uPAR and overexpression of p16 using a bicistronic vector might cause a additive and cooperative effect in the suppression of glioma invasion and growth. The bicistronic construct (Ad-uPAR/p16)-infected glioblastoma cell lines had significantly lower levels of uPAR and higher levels of p16 than controls. Cell cycle analysis showed the bicistronic vector caused G0/G1 arrest of the cell cycle. In vitro glioblastoma cell growth and invasiveness were inhibited in Ad-uPAR/p16-infected cells compared with controls. Ad-uPAR/p16 suppressed the tumor growth of glioblastoma cell lines in an ex vivo intracerebral tumor model and an in vivo subcutaneous tumor model. Our results support the therapeutic potential of simultaneously targeting uPAR and p16 in the treatment of gliomas.Entities:
Mesh:
Substances:
Year: 2002 PMID: 11791179 DOI: 10.1038/sj.onc.1204999
Source DB: PubMed Journal: Oncogene ISSN: 0950-9232 Impact factor: 9.867